Physician profile
Devin Speight
NPI 1831768480
$841.31
in general payments reported to CMS, 2019-2025
8 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.26 · 2022: $20.16 · 2023: $287 · 2024: $244 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $246.07 | 2023 | Tepezza |
| Amgen INC. | $118.89 | 2025 | Tepezza |
| Dompe US, INC. | $116.61 | 2025 | Oxervate |
| Astellas Pharma US INC | $105.76 | 2024 | Izervay |
| Lkc Technologies, INC. | $90.72 | 2024 | |
| Coopervision INC. | $88.31 | 2023-2024 | Myday Contact Lens |
| Alcon Vision LLC | $48.42 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $26.53 | 2025 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Speight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.